Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Noha M. Zaki. (2016) Strategies for oral delivery and mitochondrial targeting of CoQ10. Drug Delivery 23:6, pages 1868-1881.
Read now
Read now
Jiankang Liu & Bruce N. Ames. (2005) Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutritional Neuroscience 8:2, pages 67-89.
Read now
Read now
Gordon S Lynch. (2004) Emerging drugs for sarcopenia: age-related muscle wasting. Expert Opinion on Emerging Drugs 9:2, pages 345-361.
Read now
Read now
Gordon S Lynch. (2004) Update on therapies for sarcopenia: novel approaches for age-related muscle wasting and weakness. Expert Opinion on Therapeutic Patents 14:9, pages 1329-1344.
Read now
Read now
Articles from other publishers (25)
Monika Scheer, Anna M. Bischoff, Peter Kruzliak, Radka Opatrilova, Douglas Bovell & Dietrich Büsselberg. (2016) Creatine and creatine pyruvate reduce hypoxia-induced effects on phrenic nerve activity in the juvenile mouse respiratory system. Experimental and Molecular Pathology 101:1, pages 157-162.
Crossref
Crossref
J. David Spence & George K. Dresser. (2016) Overcoming Challenges With Statin Therapy. Journal of the American Heart Association 5:1.
Crossref
Crossref
Gregory M. Enns. (2014) Treatment of Mitochondrial Disorders. Journal of Child Neurology 29:9, pages 1235-1240.
Crossref
Crossref
Theo Wallimann, Malgorzata Tokarska-Schlattner & Uwe Schlattner. (2011) The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40:5, pages 1271-1296.
Crossref
Crossref
M. A. Tarnopolsky. (2011) Creatine as a therapeutic strategy for myopathies. Amino Acids 40:5, pages 1397-1407.
Crossref
Crossref
Ravikumar Hosamani, Saraf R. Ramesh & Muralidhara. (2010) Attenuation of Rotenone-Induced Mitochondrial Oxidative Damage and Neurotoxicty in Drosophila melanogaster Supplemented with Creatine. Neurochemical Research 35:9, pages 1402-1412.
Crossref
Crossref
Cheryl Sadowski & Shirley Heschuk. 2010. Parkinson Disease. Parkinson Disease
75
106
.
Namsoo ChangEunJung KimKi Nam KimHyesook KimSeong Yoon KimBum Seok Jeong. (2009) Folate nutrition is related to neuropsychological functions in the elderly. Nutrition Research and Practice 3:1, pages 43.
Crossref
Crossref
Peter J. Adhihetty & M. Flint Beal. (2008) Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases. NeuroMolecular Medicine 10:4, pages 275-290.
Crossref
Crossref
Michael S Schober, Glyn Chidlow, John PM Wood & Robert J Casson. (2008) Bioenergetic-based neuroprotection and glaucoma. Clinical & Experimental Ophthalmology 36:4, pages 377-385.
Crossref
Crossref
Jiankang Liu. 2008. Lipoic Acid. Lipoic Acid.
Andreas Bender, Walter Samtleben, Matthias Elstner & Thomas Klopstock. (2008) Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutrition Research 28:3, pages 172-178.
Crossref
Crossref
Jiankang Liu. (2007) The Effects and Mechanisms of Mitochondrial Nutrient α-Lipoic Acid on Improving Age-Associated Mitochondrial and Cognitive Dysfunction: An Overview. Neurochemical Research 33:1, pages 194-203.
Crossref
Crossref
Marcus Deschauer & Stephan Zierz. 2008. Pediatric Ophthalmology, Neuro-Ophthalmology, Genetics. Pediatric Ophthalmology, Neuro-Ophthalmology, Genetics
267
282
.
John M. Land, Simon J. R. Heales, Andrew J. Duncan & Iain P. Hargreaves. (2006) Some Observations upon Biochemical Causes of Ataxia and a New Disease Entity Ubiquinone, CoQ10 Deficiency. Neurochemical Research 32:4-5, pages 837-843.
Crossref
Crossref
Margaret E. Brosnan, Erica E. Edison, Robin da Silva & John T. Brosnan. (2007) New insights into creatine function and synthesis. Advances in Enzyme Regulation 47:1, pages 252-260.
Crossref
Crossref
Autumn M. Klein & Robert J. Ferrante. 2007. Creatine and Creatine Kinase in Health and Disease. Creatine and Creatine Kinase in Health and Disease
205
243
.
Mark A. Tarnopolsky. 2007. Creatine and Creatine Kinase in Health and Disease. Creatine and Creatine Kinase in Health and Disease
183
204
.
Bruce Ames & Jiankang Liu. 2005. Oxidative Stress and Age-Related Neurodegeneration. Oxidative Stress and Age-Related Neurodegeneration
59
105
.
Hoon Ryu, H. Diana Rosas, Steven M. Hersch & Robert J. Ferrante. (2005) The therapeutic role of creatine in Huntington's disease. Pharmacology & Therapeutics 108:2, pages 193-207.
Crossref
Crossref
G.D. ZeevalkL.P. BernardC. SongM. GluckJ. Ehrhart. (2005) Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration. Antioxidants & Redox Signaling 7:9-10, pages 1117-1139.
Crossref
Crossref
Mark Berneburg, Tobias Gremmel, Viola Kürten, Peter Schroeder, Ines Hertel, Anna von Mikecz, Susanne Wild, Min Chen, Lieve Declercq, Mary Matsui, Thomas Ruzicka & Jean Krutmann. (2005) Creatine Supplementation Normalizes Mutagenesis of Mitochondrial DNA as Well as Functional Consequences. Journal of Investigative Dermatology 125:2, pages 213-220.
Crossref
Crossref
Bryan S. Judge & Bernard H. Eisenga. (2005) Disorders of Fuel Metabolism: Medical Complications Associated with Starvation, Eating Disorders, Dietary Fads, and Supplements. Emergency Medicine Clinics of North America 23:3, pages 789-813.
Crossref
Crossref
S. J. TabriziA. M. BlamireD. N. MannersB. RajagopalanP. StylesA.H.V. SchapiraT. T. Warner. (2005) High-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study. Neurology 64:9, pages 1655-1656.
Crossref
Crossref
J A Quiroz, J Singh, T D Gould, K D Denicoff, C A ZarateJrJr & H K Manji. (2004) Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Molecular Psychiatry 9:8, pages 756-776.
Crossref
Crossref